Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara A Poston

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|May 28, 2004
Cefazolin tolerance does not predict ceftriaxone hypersensitivity: unique side chains precipitate anaphylaxisSara A Poston, Heath R Jennings, Kevin L Poe
Journal of Oncology Practice|September 24, 2015
ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective StudyStacey DaCosta Byfield, Philip O Buck, Cori Blauer-Peterson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 29, 2009
Economic analysis of alvimopan in North American Phase III efficacy trialsTimothy J Bell, Sara A Poston, Michael D Kraft, et al.
International Journal of Hematology|January 15, 2015
Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostimDavid J Kuter, Cynthia Macahilig, Kelly M Grotzinger, et al.
Annals of Surgery|March 6, 2012
Evaluation of clinical outcomes with alvimopan in clinical practice: a national matched-cohort study in patients undergoing bowel resectionConor P Delaney, Christopher Craver, Melinda M Gibbons, et al.
American Journal of Surgery|March 16, 2010
Association of surgical care practices with length of stay and use of clinical protocols after elective bowel resection: results of a national surveyConor P Delaney, Anthony J Senagore, Todd M Gerkin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|May 28, 2004
Cefazolin tolerance does not predict ceftriaxone hypersensitivity: unique side chains precipitate anaphylaxisSara A Poston, Heath R Jennings, Kevin L Poe
Journal of Oncology Practice|September 24, 2015
ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective StudyStacey DaCosta Byfield, Philip O Buck, Cori Blauer-Peterson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 29, 2009
Economic analysis of alvimopan in North American Phase III efficacy trialsTimothy J Bell, Sara A Poston, Michael D Kraft, et al.
International Journal of Hematology|January 15, 2015
Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostimDavid J Kuter, Cynthia Macahilig, Kelly M Grotzinger, et al.
Annals of Surgery|March 6, 2012
Evaluation of clinical outcomes with alvimopan in clinical practice: a national matched-cohort study in patients undergoing bowel resectionConor P Delaney, Christopher Craver, Melinda M Gibbons, et al.
American Journal of Surgery|March 16, 2010
Association of surgical care practices with length of stay and use of clinical protocols after elective bowel resection: results of a national surveyConor P Delaney, Anthony J Senagore, Todd M Gerkin, et al.
Pageof 1